Generated by GPT-5-mini| European Renal Best Practice | |
|---|---|
| Name | European Renal Best Practice |
| Formation | 2000s |
| Type | Medical guideline body |
| Headquarters | Brussels |
| Region served | Europe |
| Parent organization | European Renal Association–European Dialysis and Transplant Association |
European Renal Best Practice is a guideline-producing body connected to the European Renal Association–European Dialysis and Transplant Association that issues clinical recommendations for nephrology across European Union, United Kingdom, Switzerland, Norway and neighboring countries. Founded within the milieu of professional associations such as the European Society of Cardiology, International Society of Nephrology, American Society of Nephrology, European Medicines Agency, and national bodies like German Society of Nephrology, it aims to harmonize care for patients with chronic kidney disease, end-stage renal disease, and acute kidney injury. Its outputs interact with regulators such as the European Commission, payers like the European Investment Bank in health projects, and academic centers including University College London, Karolinska Institutet, Université Paris-Saclay, and Hôpital Necker–Enfants Malades.
European Renal Best Practice was established amid initiatives from the European Renal Association–European Dialysis and Transplant Association, the World Health Organization, and national ministries such as the Ministry of Health (France), drawing on expertise from institutions like the University of Oxford, Harvard Medical School, University of Amsterdam, Hôpital Necker–Enfants Malades, and University Hospital Leuven. The mission emphasizes evidence-informed guidance for clinicians in nephrology, aligning with patient safety priorities seen in documents from the Council of Europe, the European Medicines Agency, and the World Health Organization. It seeks to influence policy in parallel with organizations such as the Organisation for Economic Co-operation and Development, the European Commission Directorate-General for Health and Food Safety, and national agencies like the NHS England.
Governance involves committees and working groups analogous to structures in the European Respiratory Society, European Society of Cardiology, and International Society on Thrombosis and Haemostasis, drawing representatives from academic centers such as Charité – Universitätsmedizin Berlin, Rigshospitalet, Centro Hospitalar de Lisboa Central, and professional societies including the British Renal Society, Società Italiana di Nefrologia, and Nederlandse Vereniging voor Nefrologie. Advisory links extend to regulatory agencies like the European Medicines Agency and funding bodies such as the European Research Council and the Wellcome Trust. Conflict-of-interest policies are modeled on best practices promoted by the World Health Organization and the National Institute for Health and Care Excellence.
The body issues guidelines on topics seen in nephrology practice at centers like St. Thomas' Hospital, Hospital Clínic de Barcelona, Aarhus University Hospital, and Policlinico Gemelli. Areas include dialysis modalities, transplantation immunosuppression strategies used at Oxford Transplant Centre and Utrecht University Hospital, management of glomerulonephritis akin to protocols at Hopital Necker–Enfants Malades, and care bundles for acute kidney injury modeled on initiatives from Guy's and St Thomas' NHS Foundation Trust and Massachusetts General Hospital. Recommendations reference trials run at institutions like Karolinska Institutet, Imperial College London, Johns Hopkins Hospital, Mayo Clinic, and collaboratives such as the European Renal Association-European Dialysis and Transplant Association Registry.
Methodology follows systematic review standards used by the Cochrane Collaboration, grading frameworks like GRADE Working Group, and procedures analogous to those of National Institute for Health and Care Excellence and the World Health Organization. Panels include experts from universities such as Utrecht University, University of Barcelona, Leeds Teaching Hospitals NHS Trust, and patient representatives akin to groups affiliated with Kidney Care UK and European Kidney Patients' Federation. Drafts undergo peer review by academic centers like University of Basel, University of Milan, Helsinki University Hospital, and external review by agencies such as the European Medicines Agency.
Implementation efforts partner with national societies like the French Society of Nephrology, German Society of Nephrology, and networks such as the European Society of Paediatric Nephrology, using audit tools modeled on programs from NHS England, quality registries like the European Renal Association-European Dialysis and Transplant Association Registry, and health technology assessment units such as the National Institute for Health and Care Excellence. Pilot projects have involved hospitals including Hospital Clínic de Barcelona, Rigshospitalet, St. James's University Hospital, and collaborations with academic initiatives at Karolinska Institutet and University College London Hospital. Quality metrics are compared with international benchmarks from the United States Renal Data System and registries managed by the International Society of Nephrology.
Educational outreach includes webinars and courses co-organized with institutions like European Society of Cardiology, European Society of Intensive Care Medicine, International Society of Nephrology, and universities such as University of Edinburgh, KU Leuven, Universidad Autónoma de Madrid, and University of Zurich. Research agendas intersect with consortia funded by the European Research Council, the Horizon 2020 programme, and national funders like the German Research Foundation and Agence Nationale de la Recherche. Training for trainees and fellows mirrors curricula at University College London, Charité – Universitätsmedizin Berlin, and specialized centers including Great Ormond Street Hospital.
Critiques echo disputes seen in guideline controversies involving bodies like National Institute for Health and Care Excellence, American College of Cardiology, and World Health Organization regarding conflicts of interest, methodological transparency, and applicability across disparate systems such as those in Poland, Greece, Portugal, and Romania. Debates have referenced high-profile trials from Mayo Clinic, Johns Hopkins Hospital, and issues raised by patient advocacy groups like Kidney Care UK and European Kidney Patients' Federation, and have prompted calls for alignment with regulatory frameworks from the European Medicines Agency and deliberations in forums like the European Parliament.
Category:Nephrology organizations